Net Cash Provided by (Used in) Operating Activities |
4.6M |
USD |
|
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-600K |
USD |
-500% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-6M |
USD |
+31.8% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-2M |
USD |
+83.6% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
83.1M |
USD |
-28.3% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Valuation Allowance |
256M |
USD |
+10.2% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
266M |
USD |
+10.3% |
Q4 2023 |
FY 2023 |
Operating Lease, Liability |
46.3M |
USD |
-6.65% |
Q3 2024 |
Q3 2024 |
Lessee, Operating Lease, Liability, to be Paid |
76.7M |
USD |
-12.6% |
Q3 2024 |
Q3 2024 |
Operating Lease, Liability, Current |
4.2M |
USD |
+35.5% |
Q3 2024 |
Q3 2024 |
Lessee, Operating Lease, Liability, to be Paid, Year Two |
11.3M |
USD |
0% |
Q3 2024 |
Q3 2024 |
Lessee, Operating Lease, Liability, to be Paid, Year One |
11.3M |
USD |
+4.63% |
Q3 2024 |
Q3 2024 |
Operating Lease, Weighted Average Discount Rate, Percent |
0.16 |
pure |
0% |
Q4 2023 |
FY 2023 |
Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
30.4M |
USD |
-20.4% |
Q3 2024 |
Q3 2024 |
Lessee, Operating Lease, Liability, to be Paid, Year Three |
11.2M |
USD |
-1.75% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
166M |
USD |
+5.25% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Unrecognized Tax Benefits |
1.4M |
USD |
+40% |
Q3 2024 |
Q3 2024 |
Lessee, Operating Lease, Liability, to be Paid, Year Four |
11.3M |
USD |
0% |
Q3 2024 |
Q3 2024 |
Additional Paid in Capital |
938M |
USD |
+1.38% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
Share-based Payment Arrangement, Expense |
12.7M |
USD |
-53.8% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |